Moneta Group Investment Advisors LLC Bristol Myers Squibb CO Transaction History

Moneta Group Investment Advisors LLC

  • $5.03 Billion
  • Q4 2023

A detailed history of Moneta Group Investment Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Moneta Group Investment Advisors LLC holds 18,035 shares of BMY stock, worth $715,268. This represents 0.02% of its overall portfolio holdings.

Number of Shares
18,035
Previous 20,698 12.87%
Holding current value
$715,268
Previous $1.2 Million 22.98%
% of portfolio
0.02%
Previous 0.03%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 15, 2024
SELL
$48.48 - $57.85 $129,102 - $154,054
-2,663 Reduced 12.87%
18,035 $925,000
Q3 2023

Nov 15, 2023
SELL
$57.89 - $64.73 $240,764 - $269,212
-4,159 Reduced 16.73%
20,698 $1.2 Million
Q2 2023

Aug 15, 2023
BUY
$63.71 - $70.74 $43,322 - $48,103
680 Added 2.81%
24,857 $1.59 Million
Q1 2023

May 15, 2023
BUY
$65.71 - $74.53 $558,929 - $633,952
8,506 Added 54.28%
24,177 $1.68 Million
Q4 2022

Feb 16, 2023
SELL
$68.48 - $81.09 $397,115 - $470,240
-5,799 Reduced 27.01%
15,671 $1.13 Million
Q4 2022

Feb 16, 2023
SELL
$68.48 - $81.09 $1.47 Billion - $1.74 Billion
-21,448,315 Reduced 99.9%
21,470 $1.54 Million
Q4 2022

Feb 15, 2023
BUY
$68.48 - $81.09 $1.47 Billion - $1.74 Billion
21,451,006 Added 114228.69%
21,469,785 $1.54 Billion
Q3 2022

Nov 14, 2022
SELL
$0.13 - $76.84 $49 - $28,968
-377 Reduced 1.97%
18,779 $1.34 Million
Q2 2022

Aug 15, 2022
BUY
$72.62 - $79.98 $161,071 - $177,395
2,218 Added 13.09%
19,156 $1.48 Million
Q1 2022

May 11, 2022
SELL
$61.48 - $73.72 $3,873 - $4,644
-63 Reduced 0.37%
16,938 $1.24 Million
Q4 2021

Feb 11, 2022
SELL
$53.63 - $62.52 $116,967 - $136,356
-2,181 Reduced 11.37%
17,001 $1.06 Million
Q3 2021

Nov 12, 2021
SELL
$59.17 - $69.31 $76,388 - $89,479
-1,291 Reduced 6.31%
19,182 $1.14 Million
Q2 2021

Aug 13, 2021
BUY
$61.91 - $67.42 $102,461 - $111,580
1,655 Added 8.79%
20,473 $1.37 Million
Q1 2021

May 14, 2021
BUY
$59.34 - $66.74 $559,872 - $629,691
9,435 Added 100.55%
18,818 $1.19 Million
Q4 2020

Feb 12, 2021
BUY
$57.74 - $65.43 $74,426 - $84,339
1,289 Added 15.93%
9,383 $582,000
Q3 2020

Nov 13, 2020
SELL
$57.43 - $63.64 $176,826 - $195,947
-3,079 Reduced 27.56%
8,094 $488,000
Q2 2020

Aug 12, 2020
BUY
$54.82 - $64.09 $390,208 - $456,192
7,118 Added 175.54%
11,173 $657,000
Q1 2020

May 13, 2020
SELL
$46.4 - $67.43 $86,536 - $125,756
-1,865 Reduced 31.5%
4,055 $226,000
Q4 2019

Feb 11, 2020
SELL
$49.21 - $64.19 $111,411 - $145,326
-2,264 Reduced 27.66%
5,920 $380,000
Q3 2019

Nov 12, 2019
BUY
$42.77 - $50.71 $17,108 - $20,284
400 Added 5.14%
8,184 $415,000
Q2 2019

Aug 16, 2019
BUY
$44.62 - $49.34 $145,371 - $160,749
3,258 Added 71.98%
7,784 $353,000
Q2 2019

Aug 13, 2019
SELL
$44.62 - $49.34 $265,667 - $293,770
-5,954 Reduced 56.81%
4,526 $353,000
Q1 2019

May 16, 2019
BUY
$45.12 - $53.8 $339,528 - $404,845
7,525 Added 254.65%
10,480 $500,000
Q1 2019

May 15, 2019
SELL
$45.12 - $53.8 $275,502 - $328,502
-6,106 Reduced 67.39%
2,955 $500,000
Q4 2018

Feb 11, 2019
BUY
$48.76 - $63.23 $24,331 - $31,551
499 Added 5.83%
9,061 $471,000
Q3 2018

Nov 13, 2018
SELL
$55.19 - $62.25 $572,320 - $645,532
-10,370 Reduced 54.77%
8,562 $532,000
Q2 2018

Aug 15, 2018
SELL
$50.53 - $62.98 $250,022 - $311,625
-4,948 Reduced 20.72%
18,932 $1.05 Million
Q2 2018

Aug 14, 2018
BUY
$50.53 - $62.98 $716,414 - $892,930
14,178 Added 146.13%
23,880 $1.42 Million
Q1 2018

May 14, 2018
BUY
$59.92 - $68.98 $305,172 - $351,315
5,093 Added 110.5%
9,702 $614,000
Q4 2017

Feb 13, 2018
BUY
$59.94 - $65.35 $28,831 - $31,433
481 Added 11.65%
4,609 $282,000
Q3 2017

Nov 13, 2017
BUY
$55.23 - $63.74 $227,989 - $263,118
4,128
4,128 $263,000

Others Institutions Holding BMY

# of Institutions
2,553
Shares Held
1.49B
Call Options Held
25.9M
Put Options Held
20M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $84.3B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Moneta Group Investment Advisors LLC Portfolio

Follow Moneta Group Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moneta Group Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moneta Group Investment Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email